Scholar Rock Holding Corporation

US$46.94As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SRRKHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR 12.41%
Div yield —
ROE (167.77%)
Biotechnology
Beta (5Y) 0.79
PE TTM —
TSR TTM 58.47%
Mkt cap US$5.717B
ROIC (67.51%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$55
17.07%
(53.23%)
Buy 9|4|1|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.74
0.73
0.80
0.78
11.69%
3.50%
14.14%
6.65%
Revenue$M
258.0
266.2
262.5
277.1
(2.70%)
(3.75%)
(3.55%)
4.91%
Peers (US$5.717B)
Cap (US$)
PE
5.900B
13.54x
Capital
TTM
5Y
10Y
Leveragex
0.234
(0.080)
(0.073)
EBIT/Intx
0.253
0.215
0.266
Own earn%
10.79
24.34
25.67
Sh yield%
45.85
22.10
22.51
Owners
Insiders/Inst%
1.31
87.66
Short interest%
5.39
SBC / revenue%
5.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
21–26
$1 testx
—
Incr. ROIC%
2